138 related articles for article (PubMed ID: 2351625)
1. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
Lang CC; Moreland TA; Davey PG
J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
[TBL] [Abstract][Full Text] [Related]
2. Effect of dose and food on the bioavailability of cefuroxime axetil.
Finn A; Straughn A; Meyer M; Chubb J
Biopharm Drug Dispos; 1987; 8(6):519-26. PubMed ID: 3427209
[TBL] [Abstract][Full Text] [Related]
3. Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil.
Vasu S; Adithan C; Shashindran CH; Asad M; Koumaravelou K; Topno I
Indian J Med Res; 2000 Sep; 112():104-8. PubMed ID: 11094856
[TBL] [Abstract][Full Text] [Related]
4. Phosphate binders do not reduce bioavailability of oral cefuroxime-axetil in patients on peritoneal dialysis treatment.
Brink HS; Huisman RM; Geerlings W; de Jong PE
Adv Perit Dial; 1994; 10():179-82. PubMed ID: 7999822
[TBL] [Abstract][Full Text] [Related]
5. Effect of food on pharmacokinetics of cefuroxime axetil in Chinese subjects.
Chen RR; Lee TY; Hsieh WC
J Formos Med Assoc; 1992 Dec; 91(12):1177-81. PubMed ID: 1363640
[TBL] [Abstract][Full Text] [Related]
6. The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.
Williams PE; Harding SM
J Antimicrob Chemother; 1984 Feb; 13(2):191-6. PubMed ID: 6706890
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.
Ruiz-Carretero P; Nacher A; Merino-Sanjuan M; Casabo VG
Int J Pharm; 2000 Jul; 202(1-2):89-96. PubMed ID: 10915930
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of cefuroxime axetil formulations.
Donn KH; James NC; Powell JR
J Pharm Sci; 1994 Jun; 83(6):842-4. PubMed ID: 9120818
[TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability of cefuroxime axetil suspension formulations administered with food in healthy subjects.
Mendes GD; Borges A; de Cássia Val L; Patni AK; Reyar S; Monif T; Sereno D; Orellana AM; De Nucci G
Arzneimittelforschung; 2010; 60(2):101-5. PubMed ID: 20329659
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective absorption and hydrolysis of cefuroxime axetil diastereomers using the Caco-2 cell monolayer model.
Barrett MA; Lawrence MJ; Hutt AJ; Lansley AB
Eur J Drug Metab Pharmacokinet; 1997; 22(4):409-13. PubMed ID: 9512942
[TBL] [Abstract][Full Text] [Related]
11. Comparative investigations on the bioavailability of cefuroxime axetil.
Kees F; Lukassek U; Naber KG; Grobecker H
Arzneimittelforschung; 1991 Aug; 41(8):843-6. PubMed ID: 1781808
[TBL] [Abstract][Full Text] [Related]
12. Effect of food on the pharmacokinetics of oral cefuroxime axetil in dogs.
Albarellos GA; Passini SM; Lupi MP; Aramayona S; Lorenzini PM; Montoya L; Landoni MF
J Vet Pharmacol Ther; 2020 May; 43(3):297-302. PubMed ID: 32157713
[TBL] [Abstract][Full Text] [Related]
13. Penetration of oral cefuroxime axetil into the human aqueous humor.
Ghia M; Lotti R; Traverso C; Mattioli F; Martelli A
Ophthalmologica; 1997; 211(4):229-31. PubMed ID: 9216013
[TBL] [Abstract][Full Text] [Related]
14. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
Perry CM; Brogden RN
Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cefuroxime axetil in patients with normal and impaired renal function.
Konishi K; Suzuki H; Hayashi M; Saruta T
J Antimicrob Chemother; 1993 Mar; 31(3):413-20. PubMed ID: 8486575
[TBL] [Abstract][Full Text] [Related]
16. Model simulation of a single oral dose of cefuroxime axetil and the related in-vitro kill kinetics against four bacterial species.
Silley P; Monsey D; Harris AM
J Antimicrob Chemother; 1990 Jan; 25(1):83-90. PubMed ID: 2180892
[TBL] [Abstract][Full Text] [Related]
17. Cefuroxime axetil in acute purulent exacerbations of chronic bronchitis.
Davies BI; Maesen FP; Teengs JP
Infection; 1987; 15(4):253-6. PubMed ID: 3312021
[TBL] [Abstract][Full Text] [Related]
18. Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil.
Sommers DK; van Wyk M; Moncrieff J; Schoeman HS
Br J Clin Pharmacol; 1984 Oct; 18(4):535-9. PubMed ID: 6091711
[TBL] [Abstract][Full Text] [Related]
19. Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes.
Ruiz-Balaguer N; Nacher A; Casabo VG; Merino Sanjuan M
Int J Pharm; 2002 Mar; 234(1-2):101-11. PubMed ID: 11839441
[TBL] [Abstract][Full Text] [Related]
20. Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats.
Ruiz-Balaguer N; Nacher A; Casabo VG; Merino M
Antimicrob Agents Chemother; 1997 Feb; 41(2):445-8. PubMed ID: 9021205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
